[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100125169":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":25,"centralContacts":7,"locations":30,"responsibleParty":7,"collaborators":7,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":7,"eligibilityCriteria":55,"healthyVolunteers":56,"sex":57,"minAge":7,"maxAge":58,"enrollmentInfo":7,"targetDuration":7,"studyType":59,"phases":7,"briefSummary":60,"conditions":61,"keywords":63,"overallStatus":65,"whyStopped":7,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":7,"leadSponsor":72,"locationsCount":74},{"fullName":5,"class":6},"National Cancer Institute (NCI)","NIH",null,[9,12,14,16,18,21,23],{"type":10,"name":11,"description":7,"armGroupLabels":7,"otherNames":7},"GENETIC","DNA analysis",{"type":10,"name":13,"description":7,"armGroupLabels":7,"otherNames":7},"genetic linkage analysis",{"type":10,"name":15,"description":7,"armGroupLabels":7,"otherNames":7},"loss of heterozygosity analysis",{"type":10,"name":17,"description":7,"armGroupLabels":7,"otherNames":7},"polymorphism analysis",{"type":19,"name":20,"description":7,"armGroupLabels":7,"otherNames":7},"OTHER","laboratory biomarker analysis",{"type":19,"name":22,"description":7,"armGroupLabels":7,"otherNames":7},"medical chart review",{"type":19,"name":24,"description":7,"armGroupLabels":7,"otherNames":7},"questionnaire administration",[26],{"name":27,"affiliation":28,"role":29},"Julian Peto, MD","London School of Hygiene and Tropical Medicine","PRINCIPAL_INVESTIGATOR",[31],{"facility":28,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"RECRUITING","London","England","WC1E 7HT","United Kingdom","UK",{"type":39,"coordinates":40},"Point",[41,42],-0.12574,51.50853,{"lat":42,"lon":41},[45],{"name":27,"role":46,"phone":47,"phoneExt":7,"email":48},"CONTACT","44-20-7927-2632","julian.peto@lshtm.ac.uk","100125169","genes-and-other-risk-factors-for-second-primary-breast-cancer-in-women-with-breast-cancer-and-their-female-family-members-and-friends-100125169",false,"NCT00896818","Genes and Other Risk Factors for Second Primary Breast Cancer in Women With Breast Cancer and Their Female Family Members and Friends","The British Breast Cancer Study - National Cancer Research Network Cohort (BBC-NCRN)","DISEASE CHARACTERISTICS:\n\n* Meets 1 of the following criteria:\n\n  * Women who have been diagnosed with contralateral or unilateral breast cancer\n  * Family controls, including sisters and adult daughters of contralateral cases, female relatives by marriage\n  * Unrelated controls (i.e., friends)\n* Hormone receptor status not specified\n\nPATIENT CHARACTERISTICS:\n\n* Pre- or postmenopausal\n\nPRIOR CONCURRENT THERAPY:\n\n* Not specified",true,"FEMALE","70 Years","OBSERVATIONAL","RATIONALE: Studying samples of blood, urine, and tumor tissue in the laboratory from patients with cancer and their female relatives and friends may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.\n\nPURPOSE: This research study is looking at genes and other risk factors for second primary breast cancer in women with breast cancer and in their female family members and friends.",[62],"Breast Cancer",[64],"breast cancer","UNKNOWN","2013-08-23",{"date":68,"type":69},"2013-08-26","ESTIMATED",{"date":71,"type":7},"2005-01",{"name":73,"class":19},"Cancer Research UK",1]